Parathyroidectomy in Chronic Renal Failure: Has Medical Care Reduced the Need for Surgery?Cohen E.P. · Moulder J.E.
Departments of Medicine and Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisc., USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Subtotal or total parathyroidectomy is sometimes required for the management of severe secondary or tertiary hyperparathyroidism. Advances in medical and dialysis care may have a beneficial effect on hyperphosphatemia and vitamin D status, which could, in turn, reduce the need for parathyroidectomy. We used the United States Renal Data System to test this hypothesis. We found that the percentage of prevalent end-stage renal disease patients undergoing subtotal or total parathyroidectomy has declined significantly from 1988 to 1998. It is likely that improved medical and dialysis care has enabled this result.
© 2001 S. Karger AG, Basel
- Felsenfeld AJ: Considerations for the treatment of secondary hyperparathyroidism in renal failure. J Am Soc Nephrol 1997;8:993–1004.
- Mucsi I, Hercz G, Uldall R, Ouwendyk M, Francoeur R, Pierratos A: Control of serum phosphate without use of phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 1998;53:1399–1404.
- Demeure MJ, McFee DC, Wilkes W, Duh Q, Clark O: Results of surgical treatment for hyperparathyroidism associated with renal disease. Am J Surg 1990;160:337–340.
- Schmid T, Müller P, Spelsberg F: Parathyroidectomy after renal transplantation: A retrospective analysis of long-term outcome. Nephrol Dial Transplant 1997;12:2393–2396.
US Renal Data System, USRDS 1999 Annual Data Report. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1999.
- Decker PA, Doffek KM, Cohen EP, Ashley BA, Bienneman ME, Zhu YR, Adams MB, Wilson SD, Ahrendt SA, Demeure MJ: Subtotal parathyroidectomy in renal failure: Still needed after all these years. World J Surg 2001;25:708–712.
Aubia J, Bosch J, Lloveras J, Marinoso L, Masramon J, Serrano S, Cuevas X, Orfelia A, Llorach I, Llorach M: Low incidence of hyperparathyroidism in diabetic renal failure. Proc EDTA 1985;21:902–908.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.